TheEdgeResearch
Home / Stocks / ABMT

Advanced BioMedical Technologies Inc. (ABMT)

OTC Healthcare Medical - Devices
$0.00 ▲ +0.00%
Market Cap
$50,000
Sector
Healthcare
Industry
Medical - Devices
Beta
1.14
52-Wk Range
0.0001-0.0005
CEO
Hui Wang
Country
US
Currency
USD

Advanced BioMedical Technologies Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in New York, NY, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $50,000. On trailing twelve-month figures it carries a trailing P/E of -0.07, a net margin of -190.2%. Its beta of 1.14 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.07
Price / Sales
0.18
Price / Book
-0.00
EV / EBITDA
-41.30
Gross margin
81.9%
Operating margin
-66.4%
Net margin
-190.2%
Return on equity
Debt / equity
-0.86
Current ratio
0.04
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
17
IPO date
2008-02-21
Headquarters
New York, NY, US
About Advanced BioMedical Technologies Inc.

Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.

Comparable companies

Advanced BioMedical Technologies Inc. is most often compared with the following Healthcare names:

ASFXECGIFIORFHSMDMDXLMRRCFNUGSPTLFVRAYQWCUI
More research on ABMT
ABMT technical analysis ABMT TheEdge Score Compare against peers
Open full interactive analysis & DCF →